Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Care Property Invest NV/SA | CPINV | Nov 13, 2024 | 12.30 | -0.65 |
Celyad Oncology SA | CYAD | Nov 13, 2024 | 0.50 | -11.19 |
Cenergy Holdings | CENER | Nov 13, 2024 | 8.66 | -1.03 |
Chevron | CHTEX | Nov 13, 2024 | 170.32 | 0.00 |
Choice NV | MLTV | Nov 13, 2024 | 1.49 | 0.00 |
Cisco Systems | CIS | Nov 13, 2024 | 53.06 | 0.00 |
Cofinimmo | COFB | Nov 13, 2024 | 56.20 | -1.66 |
Cofinimmo PRF PERPETUAL EUR | COFP1 | Nov 13, 2024 | 127.00 | 0.00 |
Cofinimmo PRF PERPETUAL EUR - Registered 0% | COFP2 | Nov 13, 2024 | 95.00 | 0.00 |
Colruyt Group N.V. | COLR | Nov 13, 2024 | 44.08 | +0.36 |
Compagnie du Bois Sauvage S.A. | COMB | Nov 13, 2024 | 220.00 | -1.35 |
Compagnie d`Entreprises CFE SA | CFEB | Nov 13, 2024 | 5.80 | -1.69 |
Connect Group | CONN | Nov 13, 2024 | 1.53 | 0.00 |
Crescent NV | OPTI | Nov 13, 2024 | 0.01 | +4.00 |
Cumulex NV | CLEX | Nov 13, 2024 | 1.35 | 0.00 |
CURETIS | CURE | Nov 13, 2024 | 0.29 | 0.00 |
Deceuninck NV. | DECB | Nov 13, 2024 | 2.38 | -0.21 |
Deme Group N.V. | DEME | Nov 13, 2024 | 122.80 | -0.97 |
Deutsche Telekom AG | DTEL | Nov 13, 2024 | 20.00 | 0.00 |
Dexia SA | DEXB | Nov 13, 2024 | 0.30 | 0.00 |
Diegem KennedyCert | DIEG | Nov 13, 2024 | 109.00 | 0.00 |
Distri Land Le Certificat Foncier | DISL | Nov 13, 2024 | 192.00 | 0.00 |
DMS Imaging SA | ALIMG | Nov 13, 2024 | 0.02 | 0.00 |
DMS Imaging SA | DMSIM | Nov 13, 2024 | 0.02 | 0.00 |
D`ieteren Group | DIE | Nov 13, 2024 | 195.50 | -1.01 |
E. On SE | EON | Nov 13, 2024 | 11.32 | 0.00 |
Eckert & Ziegler BEBIG SA | EZBG | 0.00 | 0.00 | |
Econocom Group SE | ECONB | Nov 13, 2024 | 2.03 | +0.50 |
EKOPAK NV | EKOP | Nov 13, 2024 | 16.90 | +0.90 |
Elia Group SA/NV | ELI | Nov 13, 2024 | 81.90 | -3.42 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.